About this trial
The goal of this clinical trial is to learn whether a postpartum chatbot powered by generative artificial intelligence (genAI) can help new mothers get better pelvic floor health information and feel less lonely after childbirth.
The main questions this study aims to answer are:
* Does using the chatbot improve postpartum pelvic floor health knowledge? * Does using the chatbot help reduce feelings of loneliness during the postpartum period? * Does using the chatbot impact pelvic floor symptoms?
Researchers will compare standard postpartum care to standard care plus the chatbot.
Participants will:
Be assigned by chance (like flipping a coin) to standard postpartum care with or without access to the chatbot.
If in the chatbot group, participants will receive education and support via the chatbot over a 4-week period.
Both groups will complete questionnaires to measure their pelvic floor knowledge, pelvic floor symptoms, feelings of loneliness, depression, infant bonding, perceived social support, adverse childhood experiences, and peri-traumatic distress.
The chatbot was created by urogynecology experts in collaboration with UC San Diego computer science and biomedical informatics researchers. The chatbot is designed to give new mothers personalized, evidence-based information and support in real time.
Eligibility criteria
Qualifiers
Has the capacity to provide informed consent
Stated willingness to comply with all study procedures and availability for the duration of the study
Postpartum persons, aged >18 years old
Primiparous
Disqualifiers
Multiparous
Major neonatal anomaly
Delivery < 34 weeks gestational age
Intrauterine fetal demise (IUFD)
Trial design
Treatments tested in this trial
- Generative artificial intelligence (genAI) postpartum chatbot
- Standard of Care (SOC)
Treatment groups
Locations
1Sponsors and collaborators
University of California, San Diego
Lead sponsor